Facebook Linkedin RSS Twitter Youtube
Home 2023

Companion diagnostics

Precede Biosciences Launches with Cell-Free Genomic Diagnostic for Drug Development and Precision Medicine
Cancer

Precede Biosciences Launches with Cell-Free Genomic Diagnostic for Drug Development and Precision Medicine

Companion Diagnostics: Strategies for Effective Co-Development with Therapeutics
Drug Discovery

Companion Diagnostics: Strategies for Effective Co-Development with Therapeutics

Boston Calling: Genomenon Acquires Boston Genetics for Rapid Human Genome Curation
Artificial Intelligence

Boston Calling: Genomenon Acquires Boston Genetics for Rapid Human Genome Curation

Merck to Acquire Prometheus Biosciences for $10.8B
Drug Discovery

Merck to Acquire Prometheus Biosciences for $10.8B

Biosimilars and Diversification Drive Innovation in mAb Manufacturing
Artificial Intelligence

Biosimilars and Diversification Drive Innovation in mAb Manufacturing

GEN Protocols Expert Exchanges: COVID-19 Immunodiagnostic Test Identifies Antibody Source
Podcasts

GEN Protocols Expert Exchanges: COVID-19 Immunodiagnostic Test Identifies Antibody Source

Agilent CEO Talks Diagnostics, Genomics, and 2022 Headwinds
Bioprocessing

Agilent CEO Talks Diagnostics, Genomics, and 2022 Headwinds

Advancing Liquid Biopsy Companion Diagnostics with a Novel Sequencing Initiative
Sponsored

Advancing Liquid Biopsy Companion Diagnostics with a Novel Sequencing Initiative

NYC Doubles Life Sciences Bet to $1B
News

NYC Doubles Life Sciences Bet to $1B

Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
Cancer

Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform

123...12Page 1 of 12
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.